Example: Heart Attack

Clinical Trials Sponsored by Scios, Inc

Total 37 results

NCT00653042

Completed

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

Conditions: Coronary Artery Bypass Surgery; Coronary Heart Disease; Coronary Artery Bypass Grafting; Cardiopulmonary Bypass; Ischemic Heart Disease; Congestive Heart Failure
NCT00652652

Completed

Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS

Conditions: Congestive Heart Failure; Chronic Heart Failure
NCT00530426

Completed

Heart Failure Registry

Conditions: Heart Failure, Congestive
NCT00530361

Withdrawn

An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)

Conditions: Coronary Artery Bypass Surgery; Coronary Heart Disease; Coronary Artery Bypass Grafting; Cardiopulmonary Bypass; Ischemic Heart Disease; Heart Failure, Congestive
NCT00508768

Completed

A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT00475852

Completed

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Conditions: Heart Decompensation
NCT00366639

Completed

Registry for Acute Decompensated Heart Failure Patients

Conditions: Heart Failure, Congestive; Heart Decompensation
NCT00364416

Completed

Longitudinal Registry for Advanced Heart Failure Patients

Conditions: Heart Failure, Congestive; Heart Decompensation
NCT00364325

Completed

Registry for Acute Decompensated Heart Failure Patients Admitted to the ER

Conditions: Heart Failure, Congestive; Heart Decompensation
NCT00338455

Terminated

Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

Conditions: Congestive Heart Failure; Cardiac Transplantation; Renal Insufficiency; Renal Failure
NCT00288730

Completed

A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest

Conditions: Heart Failure, Congestive; Heart Decompensation
NCT00271557

Completed

A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels

Conditions: Heart Failure, Congestive; Heart Decompensation
NCT00270400

Completed

A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure

Conditions: Heart Failure, Congestive
NCT00270387

Completed

A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy

Conditions: Cardiomyopathies; Heart Failure, Congestive; Dyspnea, Paroxysma
NCT00270374

Completed

A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.

Conditions: Symptomatic Decompensated Congestive Heart Failure; Congestive Heart Failure in Acute Coronary Syndrome
NCT00270361

Completed

FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.

Conditions: Heart Failure, Congestive
NCT00113893

Completed

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Conditions: Bone Marrow Diseases; Myelodysplastic Syndromes; Hematologic Diseases; Bone Marrow Neoplasms
NCT00095680

Completed

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Conditions: Multiple Myeloma
NCT00091520

Completed

A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure

Conditions: Heart Failure, Congestive
NCT00089921

Completed

SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

Conditions: Arthritis, Rheumatoid
NCT00087867

Completed

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Conditions: Multiple Myeloma
NCT00043732

Completed

Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate

Conditions: Rheumatoid Arthritis
NCT00709163

Completed

Nesiritide - Dilated Cardiomyopathy

Conditions: Dilated Cardiomyopathy
NCT00559338

Completed

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Conditions: Heart Failure, Congestive; Cardiomyopathy
NCT00505791

Withdrawn

Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF

Conditions: Heart Failure, Congestive; Dyspnea; Pulmonary Edema